Paper39587785
Guideline for pharmacological treatment of schizophrenia 2022.
Japanese Society of Neuropsychopharmacology and 1 other. Neuropsychopharmacol Rep, 2025. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Guideline for pharmacological treatment of schizophrenia 2022. Papers, record 39587785. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39587785
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References337
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22250585 | Drug-induced parkinsonism in the elderly: incidence, management and prevention. | Drugs Aging | 2012 | https://conductscience.org/library/papers/22250585 | PubMed |
| 2 | 15846598 | Electroconvulsive therapy for schizophrenia. | Cochrane Database Syst Rev | 2005 | https://conductscience.org/library/papers/15846598 | PubMed |
| 3 | 23602690 | Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. | Eur Neuropsychopharmacol | 2013 | https://conductscience.org/library/papers/23602690 | PubMed |
| 4 | 2863986 | Neuroleptic malignant syndrome. | Am J Psychiatry | 1985 | https://conductscience.org/library/papers/2863986 | PubMed |
| 5 | 29730938 | Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. | Am J Psychiatry | 2018 | https://conductscience.org/library/papers/29730938 | PubMed |
| 6 | 24023549 | Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone. | Clin Psychopharmacol Neurosci | 2013 | https://conductscience.org/library/papers/24023549 | PubMed |
| 7 | 15784157 | A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. | Int J Neuropsychopharmacol | 2005 | https://conductscience.org/library/papers/15784157 | PubMed |
| 8 | 23983927 | Clozapine-related EEG changes and seizures: dose and plasma-level relationships. | Ther Adv Psychopharmacol | 2011 | https://conductscience.org/library/papers/23983927 | PubMed |
| 9 | 15206667 | Dose response and dose equivalence of antipsychotics. | J Clin Psychopharmacol | 2004 | https://conductscience.org/library/papers/15206667 | PubMed |
| 10 | 11219487 | Bodyweight gain with atypical antipsychotics. A comparative review. | Drug Saf | 2001 | https://conductscience.org/library/papers/11219487 | PubMed |
| 11 | 20643634 | The assessment and treatment of water imbalance in patients with psychosis. | Clin Schizophr Relat Psychoses | 2010 | https://conductscience.org/library/papers/20643634 | PubMed |
| 12 | 16172203 | Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16172203 | PubMed |
| 13 | 15762814 | The effects of benzodiazepines on cognition. | J Clin Psychiatry | 2005 | https://conductscience.org/library/papers/15762814 | PubMed |
| 14 | 32110026 | Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. | Neuropsychiatr Dis Treat | 2020 | https://conductscience.org/library/papers/32110026 | PubMed |
| 15 | 26651392 | Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study. | Am J Psychiatry | 2016 | https://conductscience.org/library/papers/26651392 | PubMed |
| 16 | 12416597 | Clozapine-induced fevers and 1-year clozapine discontinuation rate. | J Clin Psychiatry | 2002 | https://conductscience.org/library/papers/12416597 | PubMed |
| 17 | 29431197 | Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia. | Acta Psychiatr Scand | 2018 | https://conductscience.org/library/papers/29431197 | PubMed |
| 18 | 9659857 | Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. | Am J Psychiatry | 1998 | https://conductscience.org/library/papers/9659857 | PubMed |
| 19 | 8515788 | Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8515788 | PubMed |
| 20 | 23881657 | Intermittent drug techniques for schizophrenia. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23881657 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958153 | Pathways to medication adherence: a configurational analysis of psychiatric symptoms and medication attitude in patients with schizophrenia spectrum disorder receiving long-acting injectable antipsychotics. | BMC Psychiatry | 2026 | https://conductscience.org/library/papers/42958153 | PubMed |
| 42952012 | Antipsychotic Prescriptions for Prenatal and Postpartum Women in Japan: A Large Claims Database Study. | Pharmacol Res Perspect | 2026 | https://conductscience.org/library/papers/42952012 | PubMed |
| 42882078 | Extensive Craniofacial Trauma Caused by an Intraoral Pyrotechnic Explosion in a Patient with Paranoid Schizophrenia. | J Clin Med | 2026 | https://conductscience.org/library/papers/42882078 | PubMed |
| 42668991 | Physical Therapies and Neuromodulation for Treatment-Resistant Schizophrenia: A Review of Potential Mechanisms, Efficacy, and Safety. | Neuropsychiatr Dis Treat | 2026 | https://conductscience.org/library/papers/42668991 | PubMed |
| 42540002 | Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance-pharmacodynamic analysis using VigiBase. | Ther Adv Psychopharmacol | 2026 | https://conductscience.org/library/papers/42540002 | PubMed |
| 42466381 | Nationwide expansion of the EGUIDE project in Japan: A nine-year overview. | PCN Rep | 2026 | https://conductscience.org/library/papers/42466381 | PubMed |
| 42309543 | Changes in White Blood Cell and Neutrophil Counts in Patients With Schizophrenia Treated With Lithium Carbonate, Adenine, and Ninjin-Yoei-To: A Preliminary Study. | Neuropsychopharmacol Rep | 2026 | https://conductscience.org/library/papers/42309543 | PubMed |
| 42230659 | Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025. | Schizophrenia (Heidelb) | 2026 | https://conductscience.org/library/papers/42230659 | PubMed |
| 42212910 | Clozapine-Associated Neutropenia among People on Clozapine in Japan: A Nationally Representative Retrospective Cohort Study. | Schizophr Bull | 2026 | https://conductscience.org/library/papers/42212910 | PubMed |
| 42117812 | Peripheral Transcriptomic Signatures Reveal Convergent Neuroinflammatory, Metabolic, and miRNA Dysregulation in Major Psychiatric Disorders. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42117812 | PubMed |
| 42102176 | The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate. | Int J Neuropsychopharmacol | 2026 | https://conductscience.org/library/papers/42102176 | PubMed |
| 41929365 | Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a post hoc analysis of post-marketing surveillance data in Japan. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/41929365 | PubMed |
| 41756453 | Distress as a bridge to suicidality in schizophrenia spectrum disorders: a network-based intervention simulation study. | Res Sq | 2026 | https://conductscience.org/library/papers/41756453 | PubMed |
| 41069660 | Factors associated with treatment failure after discharge in inpatients with schizophrenia spectrum disorders: A retrospective observational study. | PCN Rep | 2025 | https://conductscience.org/library/papers/41069660 | PubMed |
| 40678008 | Awareness and management of cognitive impairment associated with schizophrenia in psychiatrists and patients: Results from a cross-sectional survey. | Schizophr Res Cogn | 2025 | https://conductscience.org/library/papers/40678008 | PubMed |
| 39587785 | Guideline for pharmacological treatment of schizophrenia 2022. | Neuropsychopharmacol Rep | 2025 | https://conductscience.org/library/papers/39587785 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39587785
GET https://conductscience.org/api/papers/v1/39587785/references?page=2